 | • レポートコード：MRC2-11QY04382 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は増殖性糖尿病性網膜症のグローバル市場について調査・分析したレポートです。種類別（抗VEGF剤、コルチコステロイド）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別増殖性糖尿病性網膜症の競争状況、市場シェア ・世界の増殖性糖尿病性網膜症市場：種類別市場規模 2015年-2020年（抗VEGF剤、コルチコステロイド） ・世界の増殖性糖尿病性網膜症市場：種類別市場規模予測 2021年-2026年（抗VEGF剤、コルチコステロイド） ・世界の増殖性糖尿病性網膜症市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の増殖性糖尿病性網膜症市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の増殖性糖尿病性網膜症市場分析：米国、カナダ ・ヨーロッパの増殖性糖尿病性網膜症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの増殖性糖尿病性網膜症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の増殖性糖尿病性網膜症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの増殖性糖尿病性網膜症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Intas Pharmaceuticals、Santen Pharmaceutical、Bausch Health、Allergan Plc、Regeneron Pharmaceuticals、Merck KGaA、Cipla、Genentech, Inc. (Roche Holdings)、Novartis、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Market
The global Proliferative Diabetic Retinopathy market size is projected to reach US$ 455.6 million by 2026, from US$ 430.5 million in 2020, at a CAGR of 5.4%% during 2021-2026.
Global Proliferative Diabetic Retinopathy Scope and Market Size
Proliferative Diabetic Retinopathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Proliferative Diabetic Retinopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Intas Pharmaceuticals
Santen Pharmaceutical
Bausch Health
Allergan Plc
Regeneron Pharmaceuticals
Merck KGaA
Cipla
Genentech, Inc. (Roche Holdings)
Novartis
Pfizer
Market segment by Type, the product can be split into
Anti-VEGF Agents
Corticosteroids
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue
1.4 Market by Type
1.4.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-VEGF Agents
1.4.3 Corticosteroids
1.5 Market by Application
1.5.1 Global Proliferative Diabetic Retinopathy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Proliferative Diabetic Retinopathy Market Perspective (2015-2026)
2.2 Global Proliferative Diabetic Retinopathy Growth Trends by Regions
2.2.1 Proliferative Diabetic Retinopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Proliferative Diabetic Retinopathy Historic Market Share by Regions (2015-2020)
2.2.3 Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Proliferative Diabetic Retinopathy Market Growth Strategy
2.3.6 Primary Interviews with Key Proliferative Diabetic Retinopathy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Proliferative Diabetic Retinopathy Players by Market Size
3.1.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue (2015-2020)
3.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Players (2015-2020)
3.1.3 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Proliferative Diabetic Retinopathy Market Concentration Ratio
3.2.1 Global Proliferative Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Revenue in 2019
3.3 Proliferative Diabetic Retinopathy Key Players Head office and Area Served
3.4 Key Players Proliferative Diabetic Retinopathy Product Solution and Service
3.5 Date of Enter into Proliferative Diabetic Retinopathy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Type (2015-2020)
4.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
5.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Proliferative Diabetic Retinopathy Market Size (2015-2020)
6.2 Proliferative Diabetic Retinopathy Key Players in North America (2019-2020)
6.3 North America Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
6.4 North America Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Proliferative Diabetic Retinopathy Market Size (2015-2020)
7.2 Proliferative Diabetic Retinopathy Key Players in Europe (2019-2020)
7.3 Europe Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
7.4 Europe Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
8 China
8.1 China Proliferative Diabetic Retinopathy Market Size (2015-2020)
8.2 Proliferative Diabetic Retinopathy Key Players in China (2019-2020)
8.3 China Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
8.4 China Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Proliferative Diabetic Retinopathy Market Size (2015-2020)
9.2 Proliferative Diabetic Retinopathy Key Players in Japan (2019-2020)
9.3 Japan Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
9.4 Japan Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Proliferative Diabetic Retinopathy Market Size (2015-2020)
10.2 Proliferative Diabetic Retinopathy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
10.4 Southeast Asia Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
11 India
11.1 India Proliferative Diabetic Retinopathy Market Size (2015-2020)
11.2 Proliferative Diabetic Retinopathy Key Players in India (2019-2020)
11.3 India Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
11.4 India Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Proliferative Diabetic Retinopathy Market Size (2015-2020)
12.2 Proliferative Diabetic Retinopathy Key Players in Central & South America (2019-2020)
12.3 Central & South America Proliferative Diabetic Retinopathy Market Size by Type (2015-2020)
12.4 Central & South America Proliferative Diabetic Retinopathy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Intas Pharmaceuticals
13.1.1 Intas Pharmaceuticals Company Details
13.1.2 Intas Pharmaceuticals Business Overview
13.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
13.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2015-2020))
13.1.5 Intas Pharmaceuticals Recent Development
13.2 Santen Pharmaceutical
13.2.1 Santen Pharmaceutical Company Details
13.2.2 Santen Pharmaceutical Business Overview
13.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction
13.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.2.5 Santen Pharmaceutical Recent Development
13.3 Bausch Health
13.3.1 Bausch Health Company Details
13.3.2 Bausch Health Business Overview
13.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction
13.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.3.5 Bausch Health Recent Development
13.4 Allergan Plc
13.4.1 Allergan Plc Company Details
13.4.2 Allergan Plc Business Overview
13.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction
13.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.4.5 Allergan Plc Recent Development
13.5 Regeneron Pharmaceuticals
13.5.1 Regeneron Pharmaceuticals Company Details
13.5.2 Regeneron Pharmaceuticals Business Overview
13.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
13.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.5.5 Regeneron Pharmaceuticals Recent Development
13.6 Merck KGaA
13.6.1 Merck KGaA Company Details
13.6.2 Merck KGaA Business Overview
13.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction
13.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.6.5 Merck KGaA Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview
13.7.3 Cipla Proliferative Diabetic Retinopathy Introduction
13.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Genentech, Inc. (Roche Holdings)
13.8.1 Genentech, Inc. (Roche Holdings) Company Details
13.8.2 Genentech, Inc. (Roche Holdings) Business Overview
13.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction
13.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.8.5 Genentech, Inc. (Roche Holdings) Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Proliferative Diabetic Retinopathy Introduction
13.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction
13.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Proliferative Diabetic Retinopathy Key Market Segments
Table 2. Key Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue
Table 3. Ranking of Global Top Proliferative Diabetic Retinopathy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-VEGF Agents
Table 6. Key Players of Corticosteroids
Table 7. Global Proliferative Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Proliferative Diabetic Retinopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Proliferative Diabetic Retinopathy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Proliferative Diabetic Retinopathy Market Share by Regions (2015-2020)
Table 11. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Proliferative Diabetic Retinopathy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Proliferative Diabetic Retinopathy Market Growth Strategy
Table 17. Main Points Interviewed from Key Proliferative Diabetic Retinopathy Players
Table 18. Global Proliferative Diabetic Retinopathy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Proliferative Diabetic Retinopathy Market Share by Players (2015-2020)
Table 20. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2019)
Table 21. Global Proliferative Diabetic Retinopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Proliferative Diabetic Retinopathy Product Solution and Service
Table 24. Date of Enter into Proliferative Diabetic Retinopathy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Proliferative Diabetic Retinopathy Market Size Share by Type (2015-2020)
Table 28. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2021-2026)
Table 29. Global Proliferative Diabetic Retinopathy Market Size Share by Application (2015-2020)
Table 30. Global Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Proliferative Diabetic Retinopathy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 34. North America Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 36. North America Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 38. Europe Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 40. Europe Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 42. Europe Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 44. China Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 46. China Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 47. China Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 48. China Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 49. China Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 50. Japan Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 52. Japan Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 54. Japan Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 58. Southeast Asia Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 60. Southeast Asia Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 62. India Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 64. India Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 65. India Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 66. India Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 67. India Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Proliferative Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Proliferative Diabetic Retinopathy Market Share (2019-2020)
Table 70. Central & South America Proliferative Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Proliferative Diabetic Retinopathy Market Share by Type (2015-2020)
Table 72. Central & South America Proliferative Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Proliferative Diabetic Retinopathy Market Share by Application (2015-2020)
Table 74. Intas Pharmaceuticals Company Details
Table 75. Intas Pharmaceuticals Business Overview
Table 76. Intas Pharmaceuticals Product
Table 77. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 78. Intas Pharmaceuticals Recent Development
Table 79. Santen Pharmaceutical Company Details
Table 80. Santen Pharmaceutical Business Overview
Table 81. Santen Pharmaceutical Product
Table 82. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 83. Santen Pharmaceutical Recent Development
Table 84. Bausch Health Company Details
Table 85. Bausch Health Business Overview
Table 86. Bausch Health Product
Table 87. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 88. Bausch Health Recent Development
Table 89. Allergan Plc Company Details
Table 90. Allergan Plc Business Overview
Table 91. Allergan Plc Product
Table 92. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 93. Allergan Plc Recent Development
Table 94. Regeneron Pharmaceuticals Company Details
Table 95. Regeneron Pharmaceuticals Business Overview
Table 96. Regeneron Pharmaceuticals Product
Table 97. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 98. Regeneron Pharmaceuticals Recent Development
Table 99. Merck KGaA Company Details
Table 100. Merck KGaA Business Overview
Table 101. Merck KGaA Product
Table 102. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 103. Merck KGaA Recent Development
Table 104. Cipla Company Details
Table 105. Cipla Business Overview
Table 106. Cipla Product
Table 107. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 108. Cipla Recent Development
Table 109. Genentech, Inc. (Roche Holdings) Business Overview
Table 110. Genentech, Inc. (Roche Holdings) Product
Table 111. Genentech, Inc. (Roche Holdings) Company Details
Table 112. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 113. Genentech, Inc. (Roche Holdings) Recent Development
Table 114. Novartis Company Details
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 118. Novartis Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Product
Table 122. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 123. Pfizer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Proliferative Diabetic Retinopathy Market Share by Type: 2020 VS 2026
Figure 2. Anti-VEGF Agents Features
Figure 3. Corticosteroids Features
Figure 4. Global Proliferative Diabetic Retinopathy Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Proliferative Diabetic Retinopathy Report Years Considered
Figure 9. Global Proliferative Diabetic Retinopathy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Proliferative Diabetic Retinopathy Market Share by Regions: 2020 VS 2026
Figure 11. Global Proliferative Diabetic Retinopathy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Proliferative Diabetic Retinopathy Market Share by Players in 2019
Figure 14. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Revenue in 2019
Figure 16. North America Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Proliferative Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
増殖性糖尿病性網膜症治療治療薬の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proliferative Diabe…- 糖尿病網膜症（DR）治療の世界市場（～2026年） Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). Market Analysis and Insights: Global Diabetic Retinopathy Treatment Market The global Diabet…
- 糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 糖尿病網膜症（DR）の世界市場（～2026年） Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…